Document is current

Article History

Accepted: 3 August 2022

First Online: 14 September 2022

Declarations

:

: No external funding was used in the preparation of this manuscript.

: Matteo Lambertini declares the following potential conflict of interest, all outside the submitted work: consultancy or advisory fees: Roche, Lilly, Novartis, AstraZeneca, Pfizer, Seagen, Gilead, MSD, Exact Sciences; speaker honoraria: Roche, Lilly, Novartis, Pfizer, Takeda, Ipsen, Sandoz, Libbs, Knight. Mario Scartozzi acted as consultant for MSD, BMS, Astra‐Zeneca, Merck, Amgen and Servier and received speaker honoraria from MSD, Mercks, Amgen, Eisai, Servier outside the submitted work. Mireille Langouo Fontsa, Marco Maria Aiello, Edoardo Migliori, Karen Willard-Gallo, and Cinzia Solinas declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Mireille Langouo and Cinzia Solinas entirely wrote the manuscript. Mireille Langouo, Marco Aiello and Cinzia Solinas drafted the manuscript, did the bibliographic search and are responsible for data accuracy. Edoardo Migliori and Mireille Langouo created the figure. Marco Aiello, Edoardo Migliori, Matteo Lambertini and Mario Scartozzi gave intellectual input and contributed to the edits of the manuscript. Cinzia Solinas supervised the entire process. All authors read the final version and agreed to final submission.